Moreover, miR-221-3p upregulation predicts a poor overall survival rate by suppressing SPINT1 expression and activating the liver hepatocyte growth factor (HGF), which leads to the formation of a favorable premetastatic niche and CRC metastasis [32]. The gene discussed is HGF; the disease is colorectal carcinoma.